20 articles
NHLBI researchers optimize collection and storage of umbilical cord blood from sickle cell-affected and healthy newborns for future stem cell therapies.
Ossium Health is banking donor bone marrow for on-demand transplant, targeting immune aging as a future healthspan intervention.
A landmark effort to bank immune-compatible stem cells matched to the majority of the US population — now terminated.
A new review examines how cryoprotectants can better preserve spermatogonial stem cells in prepubertal boys facing cancer therapy.
International assessment exposes inconsistencies in iPSC testing that could impact regenerative medicine safety and efficacy.
Study evaluates umbilical cord and placental tissues for cost-effective mesenchymal stem cell banking and regenerative medicine applications.
Scientists generate true hematopoietic stem cells from human iPSCs that repopulate multiple blood lineages long-term, rivaling cord blood transplants.
NIDCR researchers compared stromal cells from bone marrow, skin, spleen, and fat to identify which best regenerates bone and supports blood formation.
Comprehensive review reveals stem cell research advances alongside persistent challenges in clinical translation and regulation.
Amino acid-based mixtures rival or beat the gold standard for stem cell cryopreservation, potentially improving clinical outcomes.
Scientists explore safer alternatives to stem cell transplants using cellular secretions that may offer similar benefits.
A novel cryoprotectant using just 2% DMSO matches or outperforms standard methods, simplifying stem cell banking for transplants.
Researchers developed a breakthrough technique to cryopreserve cardiac endothelial cells with 95% viability for regenerative medicine.
Beijing's 301 Hospital begins recruiting adults 50+ for the world's largest stem cell antiaging clinical trial using an already-approved therapy.
New research exposes key obstacles researchers face when choosing pluripotent stem cells for regenerative medicine applications.
A new perspective outlines how stem cells, bioprinted organs, and cross-species genes could replace — not just repair — aging biology.
Interrupted cooling protocols boost cell viability in cryopreservation by optimizing freeze-thaw timing and temperature control.
Dr. Harry Adelson and Dr. Amy Killen reveal how U.S. stem cell treatments now rival international clinics for regenerative medicine.
Researchers developed a method to rejuvenate aging stem cells, extending their lifespan beyond 100 days while preserving function.
Scientists review how stem cell biology is advancing therapeutic approaches for tissue regeneration and cellular replacement therapies.
